The hidden burden of enteric infections in British Columbia, Canada, 2005-2014
the bacteria within the first hour of treatment as compared to the 12 hours taken by VCM.The in vivo systemic infection in BALB/c mice reduced MRSA infection in the kidney, liver, and blood by 13fold, 19.7-fold, and 2.7-fold, respectively.Discussions: These studies confirm VCM-AMP-PEP's as an alternative treatment for drug-resistant infections.Conclusion: VCM-AMP-PEP exhibits superior efficacy over VCM alone against drug-resistant bacteria and expanded its activity to gram negatives, showcasing the potential of this nanoformulation for treating infections caused by resistant strains.
Authors
- Marsha Taylor (ORCID: https://orcid.org/0000-0002-9343-3395)
- Eleni Galanis (ORCID: https://orcid.org/0000-0001-7702-3575)
- Dimitra Panagiotoglou (ORCID: https://orcid.org/0000-0002-6175-3634)
- Dr Eleni Galanis
Publication Details
- Journal
- International Journal of Infectious Diseases
- Published
- 2025-02-28
- DOI
- https://doi.org/10.1016/j.ijid.2024.107404
- Citations
- 1
- Primary Topic
- Clostridium difficile and Clostridium perfringens research
- Type
- article
- Field-Weighted Citation Impact
- 1.40